Announce Date | 08/05/2025 |
EPS Normalized Actual | $2.14 (Beat by $0.06) |
EPS GAAP Actual | $2.14 (Beat by $0.06) |
Revenue Actual | $1.924B |
Revenue Surprise | Beat by $1924M |
Announce Date | 09/30/2025 (Pre-Market) |
EPS Normalized Estimate | $2.79117 |
EPS GAAP Estimate | $2.79117 |
Revenue Estimate | $1.9574883B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 2.08 | -0.08217 | 1.924B | 1.98% | 193.51M |
FQ1 2025 (Mar 2025) | 1.84 | -0.18659 | 1.856B | -2.69% | 157.97M |
FQ4 2024 (Dec 2024) | 3.039 | 3.039 | 2.148B | 3.03% | 2148M |
FQ3 2024 (Sep 2024) | 0 | 0 | 2.369B | 100% | 2369M |
FQ2 2024 (Jun 2024) | 2.49 | 2.49 | 1.886B | 100% | 1886M |
FQ1 2024 (Mar 2024) | 2.89 | 2.89 | 1.906B | 100% | 1906M |
FQ4 2023 (Dec 2023) | 3.14 | 3.14 | 2.083B | 100% | 2083M |
FQ4 1993 (Dec 1993) | 0.57 | 0.57 | 0.5357B | 100% | 535.7M |
FQ4 Announce Date
09/30/2025 (Pre-Market)
Consensus EPS Estimates
2.79117
Consensus Revenue Estimates
1.9574883B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 3.89775 | -- | 3.89775 | 3.89775 | 1 |
FQ3 2027 (Sep 2027) | 2.93153 | -- | 2.93153 | 2.93153 | 1 |
FQ2 2027 (Jun 2027) | 2.5578 | -- | 2.5578 | 2.5578 | 1 |
FQ1 2027 (Mar 2027) | 2.8978 | -- | 2.8978 | 2.8978 | 1 |
FQ4 2026 (Dec 2026) | 3.6138 | -- | 3.6138 | 3.6138 | 1 |
FQ3 2026 (Sep 2026) | 2.73058 | -- | 2.73058 | 2.73058 | 1 |
FQ2 2026 (Jun 2026) | 2.6408 | 21.24 | 2.6408 | 2.6408 | 1 |
FQ1 2026 (Mar 2026) | 2.70903 | 32.08 | 2.70903 | 2.70903 | 1 |
FQ4 2025 (Dec 2025) | 3.23438 | 6.04 | 3.23438 | 3.23438 | 1 |
FQ3 2025 (Sep 2025) | 2.79117 | -- | 2.79117 | 2.79117 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 2.21B | -- | 2.21B | 2.21B | 1 |
FQ3 2027 (Sep 2027) | 2.14B | -- | 2.14B | 2.14B | 1 |
FQ2 2027 (Jun 2027) | 2.11B | -- | 2.11B | 2.11B | 1 |
FQ1 2027 (Mar 2027) | 1.9B | -- | 1.9B | 1.9B | 1 |
FQ4 2026 (Dec 2026) | 1.96B | -- | 1.96B | 1.96B | 1 |
FQ3 2026 (Sep 2026) | 2.1B | -- | 2.1B | 2.1B | 1 |
FQ2 2026 (Jun 2026) | 1.87B | -3.06 | 1.87B | 1.87B | 1 |
FQ1 2026 (Mar 2026) | 1.83B | -1.6 | 1.83B | 1.83B | 1 |
FQ4 2025 (Dec 2025) | 1.88B | -14.42 | 1.88B | 1.88B | 1 |
FQ3 2025 (Sep 2025) | 1.96B | -21.02 | 1.96B | 1.96B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
2
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 2.16217 | 2.08 | -0.08217 | -3.95% |
FQ1 2025 (Mar 2025) | 2.02659 | 1.84 | -0.18659 | -10.14% |
FQ4 2024 (Dec 2024) | 3.039 | 3.039 | 100% | |
FQ3 2024 (Sep 2024) | 0 | 0 | NAN% | |
FQ2 2024 (Jun 2024) | 2.49 | 2.49 | 100% | |
FQ1 2024 (Mar 2024) | 2.89 | 2.89 | 100% | |
FQ4 2023 (Dec 2023) | 3.14 | 3.14 | 100% | |
FQ4 1993 (Dec 1993) | 0.57 | 0.57 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $1.73B | $1.92B | $193.51M | 10.06% |
FQ1 2025 (Mar 2025) | $1.7B | $1.86B | $157.97M | 8.51% |
FQ4 2024 (Dec 2024) | $0B | $2.15B | $2148M | 100% |
FQ3 2024 (Sep 2024) | $0B | $2.37B | $2369M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.89B | $1886M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.91B | $1906M | 100% |
FQ4 2023 (Dec 2023) | $0B | $2.08B | $2083M | 100% |
FQ4 1993 (Dec 1993) | $0B | $0.54B | $535.7M | 100% |